Neuca contested PLN 500.9 million fine: what it means for Neuca stock
Published on 10/18/2026 at 13:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRegulatory risk and earnings calendar
- Neuca contested a PLN 500.9 million fine on September 21, 2026.
- Second-quarter 2026 revenue reached PLN 3.57 billion.
- Neuca stock was last quoted at PLN 706.00 on October 16, 2026 at 4:59 p.m. CEST.
- Third-quarter 2026 results are scheduled for November 19, 2026.
Neuca (ISIN PLTRFRM00018) contested a PLN 500.9 million fine announced on September 21, 2026, and said it would appeal. BIZNES24 reported that the company disputes the allegations and that the final penalty and payment date depend on the appeal process.
Fine keeps regulatory risk high
The Polish competition authority alleged that Neuca and its subsidiary ?wiat Zdrowia participated in an arrangement involving wholesale drug prices. The combined penalties for four pharmaceutical companies reached PLN 904.97 million, while Neuca's stated amount was PLN 500.9 million, according to BIZNES24. The decision gives the legal dispute a direct financial dimension, but the amount remains subject to the court process.
What does the appeal mean?
The operating picture before the dispute was mixed. Neuca reported PLN 3.57 billion in revenue and PLN 40.80 million in net income for the second quarter of 2026, compared with PLN 68.34 million in net income in the first quarter, figures reported by Investing.com. The sequential profit decline makes the legal outcome an additional variable for assessing cash flow and earnings resilience.
Three dates frame the case
On May 21, 2026, Neuca reported PLN 68.34 million in first-quarter net income. On August 27, 2026, its second-quarter report showed PLN 3.57 billion in revenue. On September 21, 2026, the company contested the PLN 500.9 million fine and outlined its appeal, with the chronology summarized by MarketScreener.
Next reporting date
The next stated company event is the third-quarter 2026 earnings release on November 19, 2026, according to MarketScreener. That report should provide the next dated operating checkpoint while the appeal remains unresolved.
Stock valuation after the September shock
Neuca was last quoted at PLN 706.00 on GPW on October 16, 2026 at 4:59 p.m. CEST. The quote sat within a 52-week range of PLN 627.00 to PLN 857.00, while market capitalization was PLN 3.2 billion as of the same market snapshot. The regulatory dispute and the next earnings report therefore frame the stock's near-term information flow.
The further course of trading is shown by the continuously updated real-time quote of Neuca stock.
Neuca stock facts
- Company: Neuca S.A.
- ISIN: PLTRFRM00018
- Ticker: NEU.WA
- Primary exchange: GPW
- Primary-exchange quote: PLN 706.00 as of October 16, 2026, 4:59 p.m. CEST
- Market capitalization: PLN 3.2 billion as of October 16, 2026
- 52-week range: PLN 627.00-857.00 as of October 16, 2026
- Sector / Industry: Healthcare / Medical - Distribution
Market context: Market report WIG 20.
